Ribas A - Search Results

1

What is the role of recombinant colony stimulating factors in bone marrow transplantation?

Aurer I, Ribas A, Gale RP. Aurer I, et al. Among authors: ribas a. Bone Marrow Transplant. 1990 Aug;6(2):79-87. Bone Marrow Transplant. 1990. PMID: 2207455 Review.

2

Hematopoietic growth factors in bone marrow transplantation: current and future directions.

Aurer I, Ribas A, Gale RP. Aurer I, et al. Among authors: ribas a. Haematologica. 1991 Mar-Apr;76(2):85-8. Haematologica. 1991. PMID: 1682224 No abstract available.

3

Should people with hepatitis C virus infection receive a bone marrow transplant?

Ribas A, Gale RP. Ribas A, et al. Bone Marrow Transplant. 1997 Jan;19(2):97-9. doi: 10.1038/sj.bmt.1700620. Bone Marrow Transplant. 1997. PMID: 9116620 No abstract available.

4

How important is hepatitis C virus (HCV)-infection in persons with acute leukemia?

Ribas A, Butturini A, Locasciulli A, Aricò M, Gale RP. Ribas A, et al. Leuk Res. 1997 Aug;21(8):785-8. doi: 10.1016/s0145-2126(97)00037-4. Leuk Res. 1997. PMID: 9379686 Review.

5

Two cancer survivors 20 years after an auto- or twin transplant.

Ribas A, Ho WG, Gale RP. Ribas A, et al. Bone Marrow Transplant. 1997 Dec;20(12):1103-4. doi: 10.1038/sj.bmt.1701020. Bone Marrow Transplant. 1997. PMID: 9466286

6

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.

Mok S, Tsoi J, Koya RC, Hu-Lieskovan S, West BL, Bollag G, Graeber TG, Ribas A. Mok S, et al. Among authors: ribas a. BMC Cancer. 2015 May 5;15:356. doi: 10.1186/s12885-015-1377-8. BMC Cancer. 2015. PMID: 25939769 Free PMC article.

7

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.

Koya RC, Kimura T, Ribas A, Rozengurt N, Lawson GW, Faure-Kumar E, Wang HJ, Herschman H, Kasahara N, Stripecke R. Koya RC, et al. Among authors: ribas a. Mol Ther. 2007 May;15(5):971-80. doi: 10.1038/mt.sj.6300126. Epub 2007 Mar 20. Mol Ther. 2007. PMID: 17375074 Free article.

8

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

Mok S, Koya RC, Tsui C, Xu J, Robert L, Wu L, Graeber T, West BL, Bollag G, Ribas A. Mok S, et al. Among authors: ribas a. Cancer Res. 2014 Jan 1;74(1):153-161. doi: 10.1158/0008-5472.CAN-13-1816. Epub 2013 Nov 18. Cancer Res. 2014. PMID: 24247719 Free PMC article.

9

Re: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.

Ribas A, Albanell J, Bellmunt J, Solé-Calvo LA. Ribas A, et al. J Natl Cancer Inst. 1997 Mar 5;89(5):395-6. doi: 10.1093/jnci/89.5.395. J Natl Cancer Inst. 1997. PMID: 9060963 No abstract available.

10

Frequent dose delays and growth factor requirements with the sequential doxorubicin-CMF schedule.

Ribas A, Albanell J, Bellmunt J, Bermejo B, Gallardo E, Vera R, Bodi R, Solé-Calvo LA. Ribas A, et al. Acta Oncol. 1997;36(7):701-4. doi: 10.3109/02841869709001340. Acta Oncol. 1997. PMID: 9490086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters